Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 19, 2023 Filed Jul 24, 2023 20:35 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001628280-23-025476 · wk-form4_1690230904.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 281,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2023 Filed Jul 13, 2023 21:10 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 331 | $22.79 | $7,543.49 |
DisclosureSEC source: 0001628280-23-024862 · wk-form4_1689282625.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,231 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 10-07-2019 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 20:40 UTC |
Rice MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 877 | $22.91 | $20,092.07 |
DisclosureSEC source: 0001628280-23-023916 · wk-form4_1688071205.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 418,912 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 20:38 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 695 | $22.91 | $15,922.45 |
DisclosureSEC source: 0001628280-23-023914 · wk-form4_1688071092.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,919 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 20:37 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 590 | $22.91 | $13,516.90 |
DisclosureSEC source: 0001628280-23-023912 · wk-form4_1688071012.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,908 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 20:35 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 489 | $22.91 | $11,202.99 |
DisclosureSEC source: 0001628280-23-023910 · wk-form4_1688070930.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,959 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:58 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · derivative · entry 6 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:58 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $23.32 | $233,200.00 |
DisclosureSEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,614 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.10 to $23.42, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:58 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 282,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 20:36 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 541 | $23.41 | $12,664.81 |
DisclosureSEC source: 0001628280-23-023458 · wk-form4_1687811752.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,612 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-19-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:58 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · derivative · entry 5 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:58 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $22.97 | $229,700.00 |
DisclosureSEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,614 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.51 to $23.23, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:58 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001628280-23-023339 · wk-form4_1687553889.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 282,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2023 Filed Jun 3, 2023 00:02 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 504 | $23.21 | $11,697.84 |
DisclosureSEC source: 0001437749-23-016547 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,614 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 31, 2023 Filed Jun 3, 2023 00:01 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 337 | $23.21 | $7,821.77 |
DisclosureSEC source: 0001437749-23-016546 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,448 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 31, 2023 Filed Jun 3, 2023 00:01 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 560 | $23.21 | $12,997.60 |
DisclosureSEC source: 0001437749-23-016545 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,153 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 31, 2023 Filed Jun 3, 2023 00:01 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 337 | $23.21 | $7,821.77 |
DisclosureSEC source: 0001437749-23-016544 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,562 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 31, 2023 Filed Jun 3, 2023 00:00 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 337 | $23.21 | $7,821.77 |
DisclosureSEC source: 0001437749-23-016543 · rdgdoc.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,445 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 31, 2023 Filed Jun 3, 2023 00:00 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 1,679 | $23.21 | $38,969.59 |
DisclosureSEC source: 0001437749-23-016542 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 419,789 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 31, 2023 Filed Jun 3, 2023 00:00 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 392 | $23.21 | $9,098.32 |
DisclosureSEC source: 0001437749-23-016541 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,498 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 31, 2023 Filed Jun 23, 2023 23:30 UTC |
Phillips GeraintSVP, Global Operations
|
SaleCommon Stock | 174 | $23.21 | $4,038.54 |
DisclosureSEC source: 0001437749-23-018319 · rdgdoc.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,333 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 25, 2023 Filed May 26, 2023 00:18 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-015899 · rdgdoc.xml · derivative · entry 6 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| May 25, 2023 Filed May 26, 2023 00:18 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $22.33 | $223,300.00 |
DisclosureSEC source: 0001437749-23-015899 · rdgdoc.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,118 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.15 to $22.45, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 25, 2023 Filed May 26, 2023 00:18 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001437749-23-015899 · rdgdoc.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:18 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-015899 · rdgdoc.xml · derivative · entry 5 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:18 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $22.14 | $221,400.00 |
DisclosureSEC source: 0001437749-23-015899 · rdgdoc.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,118 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.72 to $22.34, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:18 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001437749-23-015899 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2023 Filed May 23, 2023 21:46 UTC |
Casdin Partners Master Fund, L.P.10% owner
Casdin Capital, LLC10% owner
Casdin Partners GP, LLC10% owner
Casdin Eli10% owner
|
PurchaseCommon Stock, par value $.001 per share | 24,973 | $21.86 | $545,789.91 |
DisclosureSEC source: 0000919574-23-003449 · ownership.xml · nonDerivative · entry 2 Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner Casdin Capital, LLC · CIK 0001534261 · 10% owner Casdin Partners GP, LLC · CIK 0001534260 · 10% owner Casdin Eli · CIK 0001534264 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 150,000 F2 · ownership.nature: The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP. Read SEC document |
| May 19, 2023 Filed May 23, 2023 21:46 UTC |
Casdin Partners Master Fund, L.P.10% owner
Casdin Capital, LLC10% owner
Casdin Partners GP, LLC10% owner
Casdin Eli10% owner
|
PurchaseCommon Stock, par value $.001 per share | 50,000 | $22.55 | $1,127,430.00 |
DisclosureSEC source: 0000919574-23-003449 · ownership.xml · nonDerivative · entry 1 Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner Casdin Capital, LLC · CIK 0001534261 · 10% owner Casdin Partners GP, LLC · CIK 0001534260 · 10% owner Casdin Eli · CIK 0001534264 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 125,027 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $22.07753 to $23.0197. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP. Read SEC document |
| May 18, 2023 Filed May 19, 2023 00:31 UTC |
Casdin Partners Master Fund, L.P.10% owner
Casdin Capital, LLC10% owner
Casdin Partners GP, LLC10% owner
Casdin Eli10% owner
|
PurchaseCommon Stock, par value $.001 per share | 30,000 | $21.76 | $652,692.00 |
DisclosureSEC source: 0000919574-23-003408 · ownership.xml · nonDerivative · entry 3 Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner Casdin Capital, LLC · CIK 0001534261 · 10% owner Casdin Partners GP, LLC · CIK 0001534260 · 10% owner Casdin Eli · CIK 0001534264 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 75,027 F2 · ownership.nature: The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP. Read SEC document |
| May 17, 2023 Filed May 18, 2023 01:52 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 33,333 | $21.04 | $701,326.32 |
DisclosureSEC source: 0001437749-23-015004 · rdgdoc.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 421,468 F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 09-14-2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.18, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 17, 2023 Filed May 19, 2023 00:31 UTC |
Casdin Partners Master Fund, L.P.10% owner
Casdin Capital, LLC10% owner
Casdin Partners GP, LLC10% owner
Casdin Eli10% owner
|
PurchaseCommon Stock, par value $.001 per share | 30,027 | $21.30 | $639,445.98 |
DisclosureSEC source: 0000919574-23-003408 · ownership.xml · nonDerivative · entry 2 Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner Casdin Capital, LLC · CIK 0001534261 · 10% owner Casdin Partners GP, LLC · CIK 0001534260 · 10% owner Casdin Eli · CIK 0001534264 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 45,027 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $20.98 to $21.8582. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP. Read SEC document |
| May 16, 2023 Filed May 18, 2023 01:51 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 137 | $19.41 | $2,659.17 |
DisclosureSEC source: 0001437749-23-015001 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,713 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 16, 2023 Filed May 19, 2023 00:31 UTC |
Casdin Partners Master Fund, L.P.10% owner
Casdin Capital, LLC10% owner
Casdin Partners GP, LLC10% owner
Casdin Eli10% owner
|
PurchaseCommon Stock, par value $.001 per share | 15,000 | $20.19 | $302,835.00 |
DisclosureSEC source: 0000919574-23-003408 · ownership.xml · nonDerivative · entry 1 Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner Casdin Capital, LLC · CIK 0001534261 · 10% owner Casdin Partners GP, LLC · CIK 0001534260 · 10% owner Casdin Eli · CIK 0001534264 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 15,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $20.1643 to $20.2385. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP. Read SEC document |
| May 16, 2023 Filed Jun 23, 2023 23:31 UTC |
Phillips GeraintSVP, Global Operations
|
SaleCommon Stock | 100 | $19.41 | $1,941.00 |
DisclosureSEC source: 0001437749-23-018320 · rdgdoc.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,507 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 15, 2023 Filed May 18, 2023 01:53 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 125 | $18.71 | $2,338.75 |
DisclosureSEC source: 0001437749-23-015007 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,118 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 15, 2023 Filed May 18, 2023 01:53 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 106 | $18.71 | $1,983.26 |
DisclosureSEC source: 0001437749-23-015006 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,890 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 15, 2023 Filed May 18, 2023 01:53 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 75 | $18.71 | $1,403.25 |
DisclosureSEC source: 0001437749-23-015005 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,899 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 15, 2023 Filed May 18, 2023 01:52 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 72 | $18.71 | $1,347.12 |
DisclosureSEC source: 0001437749-23-015003 · rdgdoc.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,782 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 15, 2023 Filed May 18, 2023 01:52 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 190 | $18.71 | $3,554.90 |
DisclosureSEC source: 0001437749-23-015004 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 454,801 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock granted on February 8, 2021. Read SEC document |
| May 15, 2023 Filed May 18, 2023 01:52 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 92 | $18.71 | $1,721.32 |
DisclosureSEC source: 0001437749-23-015002 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,785 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| April 20, 2023 Filed Apr 21, 2023 23:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-010843 · rdgdoc.xml · derivative · entry 6 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| April 20, 2023 Filed Apr 21, 2023 23:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $19.25 | $192,500.00 |
DisclosureSEC source: 0001437749-23-010843 · rdgdoc.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,352 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.15 to $19.50, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 20, 2023 Filed Apr 21, 2023 23:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001437749-23-010843 · rdgdoc.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 23:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-010843 · rdgdoc.xml · derivative · entry 5 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 23:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $19.47 | $194,700.00 |
DisclosureSEC source: 0001437749-23-010843 · rdgdoc.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,352 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 11-15-2022 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.31 to $19.57, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 23:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001437749-23-010843 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 23:00 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 430 | $19.33 | $8,311.90 |
DisclosureSEC source: 0001437749-23-010842 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,062 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 7/17/2020 Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 23:00 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 292 | $19.33 | $5,644.36 |
DisclosureSEC source: 0001437749-23-010841 · rdgdoc.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,059 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 7/17/2020 Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 23:28 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 215 | $21.05 | $4,525.75 |
DisclosureSEC source: 0001437749-23-010569 · primary_doc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,492 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.